Literature DB >> 11426085

The abacavir hypersensitivity reaction and interruptions in therapy.

A E Loeliger, H Steel, S McGuirk, W S Powell, S V Hetherington.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11426085     DOI： 10.1097/00002030-200107060-00022

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  4 in total

Review 1.  Clinical pharmacogenetics implementation consortium guidelines for HLA-B genotype and abacavir dosing.

Authors:  M A Martin; T E Klein; B J Dong; M Pirmohamed; D W Haas; D L Kroetz
Journal:  Clin Pharmacol Ther       Date:  2012-02-29       Impact factor: 6.875

2.  Abacavir/lamivudine combination in the treatment of HIV: a review.

Authors:  Geetha Sivasubramanian; Emmanuel Frempong-Manso; Rodger D Macarthur
Journal:  Ther Clin Risk Manag       Date:  2010-03-03       Impact factor: 2.423

3.  HIV-Antiretroviral Therapy Induced Liver, Gastrointestinal, and Pancreatic Injury.

Authors:  Manuela G Neuman; Michelle Schneider; Radu M Nanau; Charles Parry
Journal:  Int J Hepatol       Date:  2012-03-11

4.  Antiretroviral Therapy-associated Serious and Life-threatening Toxicities.

Authors:  Alice K. Pau
Journal:  Curr Infect Dis Rep       Date:  2003-10       Impact factor: 3.663
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.